Person: Dr Daniel Billen

Dr Daniel Billen

Dr Daniel Billen has been appointed chair of the recently created Ontario Bioscience Economic Strategy Team (OBEST) advisory committee. Billen is GM Amgen Canada and was chosen to head up an initiative to develop an evergreen strategy for sustaining the province’s health sciences industry. An initiative of the Ontario Bioscience Industry Organization (OBIO) — a…

Dr Jean Rouleau

Dr Jean Rouleau has been appointed scientific director of CIHR’s Institute of Circulatory and Respiratory Health (ICRH). Rouleau replaces Dr Lori West who has served as interim scientific director since the departure of Dr Peter Liu earlier this year (R$, April 23/10). Rouleau is dean of the Univ of Montreal’s faculty of medicine and practices…

Dr Federico Rosei

Dr Federico Rosei has been awarded the Friedrich Wilhelm Bess Research Award for his research in the field of nanostructured organic and inorganic materials. Rosei, a professor at the INRS Energy Materials Telecommunications Centre, received the award from the Alexander von Humboldt Foundation….

Michelle Burris

Michelle Burris has been appointed executive VP operations and CFO at OncoGenex Pharmaceuticals Inc in Vancouver. Burris has been a member of its board of directors since its merger with Sonus Pharmaceuticals, Seattle WA, in 2008. Most recently she was VP and COO for Trubion Pharmaceuticals Inc unt